Microfluidic biopsy trapping device for the real-time monitoring of tumor microenvironment

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Holton, Angela Babetski ^a,b,c   Sinatra, Francy L ^a   Kreahling, Jenny ^b   Conway, Amy J ^a   Landis, David A ^a   Altiok, Soner ^b  

^a Cambridge   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; STAUROSPORINE; ANTINEOPLASTIC ANTIBIOTIC; ENZYME INHIBITOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPSY TECHNIQUE; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER PATIENT; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; EX VIVO STUDY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; LUNG ADENOCARCINOMA; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; MICROSCOPY; MOUSE; NONHUMAN; REAL TIME TRACKING SYSTEM; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; APOPTOSIS; BIOPSY; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; DEVICES; DRUG EFFECTS; DRUG SCREENING; HAIRLESS MOUSE; NEOPLASMS; PATHOLOGY; SCID MOUSE; TUMOR CELL CULTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOPSY; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; DOXORUBICIN; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; MICE, HAIRLESS; MICE, SCID; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASMS; STAUROSPORINE; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85009344104     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169797     Document Type: Article

References (66)

1. Society AC. Cancer Facts and Figures 2014 2014 [cited 2014 12/13/2014]. Available from: http://www. cancer. org/research/cancerfactsstatistics/cancerfactsfigures2014/index.
2. Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, Arndt K, et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics. 2009; 1(2):387-98. doi: 10. 2217/epi. 09. 25 PMID: 20495621
3. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations. Cell. 2010; 141(1):69-80. doi: 10. 1016/j. cell. 2010. 02. 027 PMID: 20371346
4. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012; 483(7391):570-5. doi: 10. 1038/nature11005 PMID: 22460902
5. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012; 487(7408):500-4. doi: 10. 1038/nature11183 PMID: 22763439
6. Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JCR, Giancotti F, et al. ?4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer cell. 2002; 2(3):205-16. PMID: 12242153
7. Yamada KM, Cukierman E. Modeling Tissue Morphogenesis and Cancer in 3D. Cell. 2007; 130 (4):601-10. doi: 10. 1016/j. cell. 2007. 08. 006 PMID: 17719539
8. Torisawa Y-s, Shiku H, Yasukawa T, Nishizawa M, Matsue T. Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test. Biomaterials. 2005; 26(14):2165-72. doi: 10. 1016/j. biomaterials. 2004. 05. 028 PMID: 15576192
9. Huang S-B, Wang S-S, Hsieh C-H, Lin YC, Lai C-S, Wu M-H. An integrated microfluidic cell culture system for high-throughput perfusion three-dimensional cell culture-based assays: effect of cell culture model on the results of chemosensitivity assays. Lab on a Chip. 2013; 13(6):1133-43. doi: 10. 1039/c2lc41264k PMID: 23353927
10. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology. 1990; 40(10):2353-62. PMID: 2244936
11. Herzog TJ, Krivak TC, Fader AN, Coleman RL. Chemosensitivity testing with ChemoFx and overall survival in primary ovarian cancer. American Journal of Obstetrics and Gynecology. 2010; 203(1):68. e1-. e6.
12. Bosserman L, Prendergast F, Herbst R, Fleisher M, Salom E, Strickland S, et al. The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care. Cancer Research. 2012; 72(16):3901-5. doi: 10. 1158/0008-5472. CAN-12-0681 PMID: 22865459
13. Wu M-H, Chang Y-H, Liu Y-T, Chen Y-M, Wang S-S, Wang H-Y, et al. Development of high throughput microfluidic cell culture chip for perfusion 3-dimensional cell culture-based chemosensitivity assay. Sensors and Actuators B: Chemical. 2011; 155(1):397-407.
14. Wu M, Urban JG, Cui Z, Cui Z. Development of PDMS microbioreactor with well-defined and homogenous culture environment for chondrocyte 3-D culture. Biomedical Microdevices. 2006; 8(4):331-40. doi: 10. 1007/s10544-006-9597-y PMID: 16917663
15. Maitland ML, DiRienzo A, Ratain MJ. Interpreting Disparate Responses to Cancer Therapy: The Role of Human Population Genetics. Journal of Clinical Oncology. 2006; 24(14):2151-7. doi: 10. 1200/JCO. 2005. 05. 2282 PMID: 16682733
16. MuEèrkoÈster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse M-L, et al. Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Microfluidics and the Tumor Microenvironment PLOS ONE | DOI:10. 1371/journal. pone. 0169797 January 13, 2017 18/21
17. Paracrine Effects of Nitric Oxide and Interleukin-1?. Cancer Research. 2004; 64(4):1331-7. PMID: 14973050
18. Taernok A, Bocsi J, Brockhoff G. Cytomics-importance of multimodal analysis of cell function and proliferation in oncology. Cell Proliferation. 2006; 39(6):495-505. doi: 10. 1111/j. 1365-2184. 2006. 00407. x PMID: 17109634
19. Wlodkowic D, Skommer J, Darzynkiewicz Z. Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry Part A. 2010; 77A(7):591-606.
20. El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature. 2006; 442(7101):403-11. doi: 10. 1038/nature05063 PMID: 16871208
21. Feng X, Du W, Luo Q, Liu B-F. Microfluidic chip: Next-generation platform for systems biology. Analytica Chimica Acta. 2009; 650(1):83-97. doi: 10. 1016/j. aca. 2009. 04. 051 PMID: 19720178
22. Whitesides GM. The origins and the future of microfluidics. Nature. 2006; 442(7101):368-73. doi: 10. 1038/nature05058 PMID: 16871203
23. Wu M-H, Urban JPG, Cui ZF, Cui Z, Xu X. Effect of Extracellular pH on Matrix Synthesis by Chondrocytes in 3D Agarose Gel. Biotechnology Progress. 2007; 23(2):430-4. doi: 10. 1021/bp060024v PMID: 17286385
24. Kim L, Toh Y-C, Voldman J, Yu H. A practical guide to microfluidic perfusion culture of adherent mammalian cells. Lab on a Chip. 2007; 7(6):681-94. doi: 10. 1039/b704602b PMID: 17538709
25. Ling Y, Rubin J, Deng Y, Huang C, Demirci U, Karp JM, et al. A cell-laden microfluidic hydrogel. Lab on a Chip. 2007; 7(6):756-62. doi: 10. 1039/b615486g PMID: 17538718
26. Nevill JT, Cooper R, Dueck M, Breslauer DN, Lee LP. Integrated microfluidic cell culture and lysis on a chip. Lab on a Chip. 2007; 7(12):1689-95. doi: 10. 1039/b711874k PMID: 18030388
27. Sung KE, Yang N, Pehlke C, Keely PJ, Eliceiri KW, Friedl A, et al. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integrative Biology. 2011; 3(4):439-50. doi: 10. 1039/c0ib00063a PMID: 21135965
28. Abbott A. Cell culture: Biology's new dimension. Nature. 2003; 424(6951):870-2. doi: 10. 1038/424870a PMID: 12931155
29. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7 (3):211-24. doi: 10. 1038/nrm1858 PMID: 16496023
30. Ng CP, Pun SH. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport. Biotechnology and bioengineering. 2008; 99(6):1490-501. doi: 10. 1002/bit. 21698 PMID: 17969174
31. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Current Opinion in Cell Biology. 2003; 15(6):753-62. PMID: 14644202
32. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends in Cell Biology. 1998; 8(11):437-41. PMID: 9854310
33. Even-Ram S, Yamada KM. Cell migration in 3D matrix. Current Opinion in Cell Biology. 2005; 17 (5):524-32. doi: 10. 1016/j. ceb. 2005. 08. 015 PMID: 16112853
34. Golden AP, Tien J. Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. Lab Chip. 2007; 7(6):720-5. doi: 10. 1039/b618409j PMID: 17538713
35. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotech. 2003; 21 (10):1171-8.
36. Hattersley SM, Sylvester DC, Dyer CE, Stafford ND, Haswell SJ, Greenman J. A microfluidic system for testing the responses of head and neck squamous cell carcinoma tissue biopsies to treatment with chemotherapy drugs. Annals of biomedical engineering. 2012; 40(6):1277-88. doi: 10. 1007/s10439-011-0428-9 PMID: 21997391
37. Komen J, Wolbers F, Franke HR, Andersson H, Vermes I, van den Berg A. Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs. Biomedical Microdevices. 2008; 10(5):727-37. doi: 10. 1007/s10544-008-9184-5 PMID: 18523888
38. Chang S-F, Chang CA, Lee D-Y, Lee P-L, Yeh Y-M, Yeh C-R, et al. Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad. Proceedings of the National Academy of Sciences. 2008; 105(10):3927-32.
39. Kawai Y, Kaidoh M, Yokoyama Y, Ohhashi T. Pivotal roles of shear stress in the microenvironmental changes that occur within sentinel lymph nodes. Cancer Science. 2012; 103(7):1245-52. doi: 10. 1111/j. 1349-7006. 2012. 02289. x PMID: 22463128
40. Qazi H, Shi Z-D, Tarbell JM. Fluid Shear Stress Regulates the Invasive Potential of Glioma Cells via Modulation of Migratory Activity and Matrix Metalloproteinase Expression. PLoS ONE. 2011; 6(5): e20348. doi: 10. 1371/journal. pone. 0020348 PMID: 21637818
41. Altiok S, Mezzadra H. , Jagannath S. , Tsottles N. , Rudek M. , Abdallah N. , Berman D. , Forastiere A. , & Gibson M. A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer. International Journal of Oncology. 2010; 36(1):19-27. PMID: 19956829
42. Koivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Letters. 2006; 235(1):1-10. doi: 10. 1016/j. canlet. 2005. 03. 033 PMID: 15907369
43. Hidalgo M, Amador ML, Jimeno A, Mezzadra H, Patel P, Chan A, et al. Assessment of gefitinib-and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration. Molecular cancer therapeutics. 2006; 5(7):1895-903. doi: 10. 1158/1535-7163. MCT-05-0525 PMID: 16891476
44. Rubio-Viqueira B, Mezzadra H, Nielsen ME, Jimeno A, Zhang X, Iacobuzio-Donahue C, et al. Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays. Molecular cancer therapeutics. 2007; 6 (2):515-23. doi: 10. 1158/1535-7163. MCT-06-0388 PMID: 17308050
45. Leclerc E, Sakai Y, Fujii T. Cell Culture in 3-Dimensional Microfluidic Structure of PDMS (polydimethylsiloxane). Biomedical Microdevices. 2003;(2
46. Telang S, Nelson KK, Siow DL, Yalcin A, Thornburg JM, Imbert-Fernandez Y, et al. Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth. Molecular Cancer. 2012.
47. Abdi H. The greenhouse-geisser correction. Encyclopedia of research design SAGE Publications Thousand Oaks, CA, USA. 2010
48. Lankelma J, Dekker H, Fernaendez Luque R, Luykx S, Hoekman K, Valk Pvd, et al. Doxorubicin Gradients in Human Breast Cancer. Clinical Cancer Research. 1999; 5(7):1703-7. PMID: 10430072
49. de Lange JHM, Schipper NW, Schuurhuis GJ, ten Kate TK, Van Heijningen THM, Pinedo HM, et al. Quantification by laser scan microscopy of intracellular doxorubicin distribution. Cytometry. 1992; 13 (6):571-6. doi: 10. 1002/cyto. 990130604 PMID: 1451589
50. Blankenberg FG. Imaging the Molecular Signatures of Apoptosis and Injury with Radiolabeled Annexin V. Proceedings of the American Thoracic Society. 2009; 6(5):469-76. doi: 10. 1513/pats. 200901-001AW PMID: 19687221
51. Mitchell MJ, King MR. Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. New journal of physics. 2013; 15:015008. doi: 10. 1088/1367-2630/15/1/015008 PMID: 25110459
52. Hatok J, Babusikova E, Matakova T, Mistuna D, Dobrota D, Racay P. In vitro assays for the evaluation of drug resistance in tumor cells. Clinical and experimental medicine. 2009; 9(1):1-7. doi: 10. 1007/s10238-008-0011-3 PMID: 18818983
53. Qi C-J, Ning Y-L, Zhu Y-L, Min H-Y, Ye H, Qian K-Q. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay. Archives of pharmacal research. 2009; 32(12):1737-42. doi: 10. 1007/s12272-009-2211-0 PMID: 20162402
54. Sittinger M, Schultz O, Keyszer G, Minuth W, Burmester G. Artificial tissues in perfusion culture. The International journal of artificial organs. 1997; 20(1):57-62. PMID: 9062833
55. Kim JB. Three-dimensional tissue culture models in cancer biology. Seminars in Cancer Biology. 2005; 15(5):365-77. doi: 10. 1016/j. semcancer. 2005. 05. 002 PMID: 15975824
56. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, et al. Engineering tumors with 3D scaffolds. Nat Meth. 2007; 4(10):855-60.
57. Håkanson M, Textor M, Charnley M. Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer. Integrative Biology. 2011; 3(1):31-8. doi: 10. 1039/c0ib00074d PMID: 21049126
58. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: highresolution measurements reveal a lack of correlation. Nature medicine. 1997; 3(2):177-82. PMID: 9018236
59. Treedan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute. 2007; 99(19):1441-54. doi: 10. 1093/jnci/djm135 PMID: 17895480
60. Couzon C, Duperray A, Verdier C. Critical stresses for cancer cell detachment in microchannels. European Biophysics Journal. 2009; 38(8):1035-47. doi: 10. 1007/s00249-009-0506-1 PMID: 19579023
61. Walker GM, Sai J, Richmond A, Stremler M, Chung CY, Wikswo JP. Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator. Lab on a Chip. 2005; 5(6):611-8. doi: 10. 1039/b417245k PMID: 15915253
62. Du Z, Cheng KH, Vaughn MW, Collie NL, Gollahon LS. Recognition and capture of breast cancer cells using an antibody-based platform in a microelectromechanical systems device. Biomedical Microdevices. 2007; 9(1):35-42. doi: 10. 1007/s10544-006-9010-x PMID: 17103049
63. LindstroÈm S, Mori K, Ohashi T, Andersson-Svahn H. A microwell array device with integrated microfluidic components for enhanced single-cell analysis. Electrophoresis. 2009; 30(24):4166-71. doi: 10. 1002/elps. 200900572 PMID: 19938185
64. Chaw K, Manimaran M, Tay E, Swaminathan S. Multi-step microfluidic device for studying cancer metastasis. Lab on a Chip. 2007; 7(8):1041-7. doi: 10. 1039/b707399m PMID: 17653347
65. Hou HW, Li Q, Lee G, Kumar A, Ong C, Lim CT. Deformability study of breast cancer cells using microfluidics. Biomedical Microdevices. 2009; 11(3):557-64. doi: 10. 1007/s10544-008-9262-8 PMID: 19082733
66. Khoury M, Bransky A, Korin N, Konak L, Enikolopov G, Tzchori I, et al. A microfluidic traps system supporting prolonged culture of human embryonic stem cells aggregates. Biomedical Microdevices. 2010; 12(6):1001-8. doi: 10. 1007/s10544-010-9454-x PMID: 20665114